Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_assertion type Assertion NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_head.
- NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_assertion wasGeneratedBy ECO_0000203 NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_provenance.
- NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_assertion wasDerivedFrom befree-20140225 NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_provenance.
- NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_assertion SIO_000772 15314693 NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_provenance.
- NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_assertion evidence source_evidence_literature NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_provenance.
- NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_assertion description "[Our results suggest that (a) deficiency in MIC-NKG2D immune surveillance may contribute to prostate cancer progression, (b) sMIC may be a novel biomarker for prostate cancer, and (c) using cytokines to restore MIC-NKG2D-mediated immunity may have clinical significance for prostate cancer in cell-based adaptive immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311222.RAKzDMiSUhtCt2417MWA2mCBhRu17dm1ZlZ-dnsdv0pWg130_provenance.